BRPI1009345A2 - sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas - Google Patents

sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas

Info

Publication number
BRPI1009345A2
BRPI1009345A2 BRPI1009345A BRPI1009345A BRPI1009345A2 BR PI1009345 A2 BRPI1009345 A2 BR PI1009345A2 BR PI1009345 A BRPI1009345 A BR PI1009345A BR PI1009345 A BRPI1009345 A BR PI1009345A BR PI1009345 A2 BRPI1009345 A2 BR PI1009345A2
Authority
BR
Brazil
Prior art keywords
delivery system
drug delivery
treating disease
disease
treating
Prior art date
Application number
BRPI1009345A
Other languages
English (en)
Inventor
Niels Honcoop
Raymond Zeeman
Wouter De Graaff
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI1009345A2 publication Critical patent/BRPI1009345A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1009345A 2009-03-17 2010-03-16 sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas BRPI1009345A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16094209P 2009-03-17 2009-03-17
EP09155383 2009-03-17
PCT/EP2010/053339 WO2010106046A1 (en) 2009-03-17 2010-03-16 Macrocyclic lactone drug delivery system

Publications (1)

Publication Number Publication Date
BRPI1009345A2 true BRPI1009345A2 (pt) 2016-03-08

Family

ID=40941503

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009345A BRPI1009345A2 (pt) 2009-03-17 2010-03-16 sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas

Country Status (11)

Country Link
US (1) US9345686B2 (pt)
EP (1) EP2408432A1 (pt)
JP (1) JP2012520847A (pt)
KR (1) KR20120006987A (pt)
CN (1) CN102355891A (pt)
AR (1) AR075846A1 (pt)
AU (1) AU2010224918A1 (pt)
BR (1) BRPI1009345A2 (pt)
CA (1) CA2755753A1 (pt)
MX (1) MX2011009678A (pt)
WO (1) WO2010106046A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3682887A1 (en) * 2010-07-30 2020-07-22 Ceva Sante Animale Compositions comprising ivermectin for treating heartworm infestation
PT2598151T (pt) * 2010-07-30 2019-04-15 Ceva Sante Animale Sa Composições para o tratamento da infestação por vermes do coração
CL2014000989A1 (es) * 2014-04-17 2014-10-17 Univ Santiago Chile Dispositivo subdermal de liberacion prolongada y lenta para prevencion, tratamiento y monitoreo de parasitos, que comprende al menos una lactona macrociclica tal como ivermectina y/o dormectina, opcionalmente nanoparticulas o microparticulas de zeolita, una matriz polimerica y medios de monitoreo, dentro de un circuito integrado.
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
WO2018064556A1 (en) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CN111989068B (zh) * 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
AU2019294615A1 (en) * 2018-06-25 2021-02-11 ReacX Pharmaceuticals, Inc. Implants for release of lipophilic or amphiphilic pharmaceutical substances
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
AUPR602501A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
JP2007530500A (ja) * 2004-03-24 2007-11-01 ナームローゼ・フエンノートチヤツプ・オルガノン ポリエチレン酢酸ビニル共重合体に基づく薬物送達システム
BRPI0504244A (pt) * 2005-09-29 2007-09-25 Clarion Biociencias Ltda implantes subdérmicos de etilenovilacetato (eva) e polydimethylsiloxane (silicone) que consiste na utilização de eva ou silicone para uso como matriz plástica endectocida, associado ou não a um ectoparasiticida e/ou igr, para confecções de implantes subdérmicos para utilização em bovinos, cães e gatos e respectivo método de produção

Also Published As

Publication number Publication date
CA2755753A1 (en) 2010-09-23
US9345686B2 (en) 2016-05-24
WO2010106046A1 (en) 2010-09-23
US20120052108A1 (en) 2012-03-01
KR20120006987A (ko) 2012-01-19
CN102355891A (zh) 2012-02-15
JP2012520847A (ja) 2012-09-10
AR075846A1 (es) 2011-04-27
EP2408432A1 (en) 2012-01-25
MX2011009678A (es) 2011-09-30
AU2010224918A1 (en) 2011-10-06

Similar Documents

Publication Publication Date Title
IL262376A (en) Method and system for drug delivery
BRPI0913214A2 (pt) sistema de fornecimento de drogas transdérmico estabilizado
BRPI0917030A2 (pt) sistema de liberação de fármaco contendo progestina
BRPI0917250A2 (pt) sistema para detecção de tecido em um paciente, sistema para detectar característica de tecido em um paciente
BRPI0916328A2 (pt) sistema e método para redução de fratura, bem como método para formação de um sistema para redução de fratura
BRPI1006885A2 (pt) sistema de completação utilizável com um poço, e método utilizável com um poço
BRPI1014139A2 (pt) sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo.
BRPI1005998A2 (pt) metodo para prover o suporte de pressao a um paciente, sistema de suporte de pressao e metodo para prover suporte de pressao a um paciente
BRPI1014771A2 (pt) dispositivo de dispensação de droga, método para carregar um dispositivo de dispensação de droga, e, sistema para carregar um dispositivo de dispensação de droga
BRPI1016147A2 (pt) sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino
BRPI1009004A2 (pt) método para integrar diagnóstico e tratamento para tecidos internos, e, sistema para integrar diagnóstico e tratamento para tecidos internos
BRPI1014975A2 (pt) sistema de entrega de implante
EP2385827A4 (en) SYSTEM FOR DOSED ADMINISTRATION OF MEDICINAL PRODUCTS
BRPI0925314A2 (pt) Sistema e método para preparar uma quantidade predeterminada de bebida, cápsula, e, uso de uma cápsula.
BRPI1008076A2 (pt) sistema, método e aparelho para implementar implantes dentários
BRPI1006922A2 (pt) sistema para descarte de medicação
BR112012025956A2 (pt) sistema médico, aparelho e método
BRPI1010950A2 (pt) método para preparação de emulsão carregada de fármaco.
BR112014021103A8 (pt) anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
EP3323405C0 (en) SYSTEM AND METHOD FOR DISPENSING MEDICATION
DK2398500T3 (da) Glutathion-baseret lægemiddelafgivelsessystem
BR112012000888A2 (pt) sistema e método para iniciar um sistema operacional multiambiente
BR112014002621A2 (pt) anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento
BRPI1016218A2 (pt) sistema, e, método
BRPI1013630A2 (pt) sistema, e método

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2369 DE 31-05-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.